Babesia microti: Pathogenesis of parasite of human origin in the hamster

The pathogenesis of the disease in hamsters caused by the first human Babesia isolant, tentatively named Babesia microti, and the immunologic relationship of the organism to Babesia canis were studied. The patent phase of the disease was characterized by severe anemia and marked parasitemia which occurred between the 6th and 41st day following infection. An increase in total white cell count with a neutrophilia, eosinophilia, monocytosis, and lymphocytosis was observed during the patent phase. The patent phase was followed by development of a carrier state. This was demonstrated by relapse following splenectomy 113 days after infection. No statistically significant differences were observed between the serum profiles of infected and noninfected animals during the period monitored. A serologic relationship between B. microti and B. canis was revealed by the use of gel diffusion and indirect fluorescent antibody (IFA) tests. The IFA test was used to monitor serum antibody responses during the patent and carrier phases of the disease. Crossabsorption studies between B. canis and B. microti revealed that the two organisms possess common and specific antigens.